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sion (ICD 10 = F06.3, F31.3, F31.4, F32, F33, F34.1, F38.1, F41.2) within 1 year 
before the ﬁ rst observed prescription of ADs between January 2007 to June 2008 
(Index period: 18 months) were identiﬁ ed. ADs were categorized as tricyclic antide-
pressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and new antidepres-
sants (NADs; SNRIs and others). For each AD category, adherence by Medication 
possession ratio (MPR) of 180 days post-index period and persistence by duration of 
uninterrupted therapy (DUR) with a 14-day permissible gap were estimated. Addi-
tional subgroup analyses by non-adherence (MPR < 75%) and by early dropout (DUR 
< 90 days) were included. Multivariable logistic regression analysis was performed to 
further investigate the relationship between AD categories and adherence (persistence). 
RESULTS: Of 318,490 patients satisﬁ ed the selection criteria, mean MPR was 0.52 
(SD = 0.34) and mean duration of uninterrupted therapy of were 118.08 days (SD = 
67.67). Non-adherence proportion was 65.9%, and early dropout rate was 36.7%. 
Patients prescribed by psychiatrists (N = 208,791) showed signiﬁ cantly higher MPR 
(0.54 vs. 0.40; P < 0.001) and persistence (125.43 vs. 102.67; P < 0.001). When 
adjusted for age, gender, pre-/post- inpatient or outpatient visits, Chalson’s comorbid-
ity index, hypertension, and hyperlipidemia, with TCA as reference, patients pre-
scribed NADs (aOR = 1.75 [1.70–1.80]) and SSRIs (aOR = 1.56 [1.52–1.60]) were 
associated higher adherence, whereas SSRIs were associated higher (aOR = 1.03 
[1.01–1.05]) but NADs were associated lower (aOR = 0.93 [0.91–0.96]) persistence. 
CONCLUSIONS: Contrary to the previous literature, Korean adherence and persis-
tence of ADs were not signiﬁ cantly lower than the United States or Europe. In addi-
tion, NADs showed an advantage in terms of adherence and SSRIs had an edge in 
terms of persistence. 
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OBJECTIVES: Hypertension (HTN) is an important and prevalent risk factor for 
cardiovascular diseases. In Taiwan, the prevalence of hypertension is around 21.4% 
and only about 40% patients with acceptable range of blood pressure control. The 
purpose of this study is to evaluate the trend of antihypertensive medications and also 
examine the risk of stroke among these HTN patients from 2001 to 2004 in Taiwan. 
METHODS: Based on the National Health Insurance (NHI) database, there are 
1,931,436 patients with ICD-9 coding of hypertension, we randomly selected 10% 
hypertension outpatients (194,547 subjects) from the NHI claim database, after 
excluded those visited less than three times or without anti-HTN medication, 135,660 
patients in the ﬁ nally analyses. These subjects follow their anti-HTN medications and 
occurrence of stroke for a 4-year period. RESULTS: Among these patients, 27.6% 
used only one medication and 37.0% with three or more medications for HTN. There 
are 9530 (4402 males and 5128 females) patients had both drug information on 2001 
and 2004. The prevalence of stoke was 7.3% in 2001 and increased to 13.6% in 2004. 
The average out-patient medical costs for hypertension were increased from 
NT$15,778.7 to 19,712.1 dollars (at an exchange rate of 32 NT$ to 1 US$) from 
2001 to 2004. Using Cox proportion hazard model, gender (male) and age were 
important factors to predict the occurrence of stroke. Comparing with beta-blocker, 
diuretics had higher relative risk for stoke but the risk was attenuate after adjusted 
for other confounders (HR = 1.3, 95% CI 0.7−2.6). CONCLUSIONS: From this 
study, the out-patient medical costs for hypertension were increased from 2001 to 
2004 in Taiwan. However, the occurrence of stroke among hypertensive patients was 
also increased during this period. There was no signiﬁ cant protective effect for stroke 
among hypertensive patients using different anti-HTN medications. Further studies 
may be indicated to evaluate the cost-effectiveness of different medications on 
hypertensive-related disorders. 
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BACKGROUND: Several statistical methods have been applied to detect signals in 
spontaneous reporting databases. The Thailand Food and Drug Administration (Thai 
FDA) uses the reporting odds ratio (ROR) method for signal detection because of its 
ease of implementation and interpretation. The performance of different methods 
needs to be explored to determine need for modiﬁ cations to the Thai FDA signal 
detection system. OBJECTIVES: To examine the concordance between the ROR and 
the Bayesian Conﬁ dence Propagation Neural Network (BCPNN) methods in identify-
ing adverse drug reaction (ADR) signals using the Thai FDA database. METHODS: 
The two methods were retrospectively applied to identify ADRs reported with anti-
retroviral (ARV) drugs using the dataset from 1990 to 2006. The criteria of lower 
limit of 95% conﬁ dence interval of ROR >1, 3 or more cases; and information com-
ponent (IC) two standard deviations >0, were used to identify signals for ROR and 
BCPNN, respectively. The sensitivity, speciﬁ city and agreement of timing of signal 
detection were measured for the concordance of the ROR in respect to the BCPNN. 
RESULTS: Using the BCPNN as a reference method, the ROR has high sensitivity 
and speciﬁ city. For the agreement of timing of signal detection between the ROR and 
the BCPNN, signals detected by both methods were in agreement on the ﬁ rst time of 
signal detection for 76.92%. CONCLUSIONS: ROR and BCPNN are comparable in 
identify signals of potential ADRs. Comparisons using other drug classes will provide 
additional insight into the performance of these two methods. 
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OBJECTIVES: The use of herbal products continues to expand rapidly across the 
world. The concerns of safety of herbal products have been raised. Health Product 
Vigilance Center (HPVC) database (Thai Vigibase) is the national existing health 
products surveillance system which can be used to detect signal of adverse events (AEs) 
in patients receiving herbal products. This study aims to describe and characterize 
reported AEs in patients receiving herbal products in Thailand. METHODS: Thai 
Vigibase data from February 2000 to December 2008 involving AEs of reported herbal 
products were included. The database contained patients’ demographic, AEs associ-
ated with herbal products, seriousness, causality and quality of reports. Descriptive 
statistics were used for data analyses. RESULTS: A total of 593 reports with 1868 
AEs were reported during the study period. The age range of reported cases was 1 to 
86 years (mean, 47 years). Female patients were frequently reported (72%). Reports 
involving turmeric were most frequently reported. Gastro-intestinal problems were the 
most common clinical outcomes among herbal products associated with adverse 
events. Severe adverse events such as Stevens Johnson syndrome, anaphylactic shock 
and exfoliative dermatitis were also found. CONCLUSIONS: HPVC database is a 
potentially effective tool for herbal adverse events monitoring. Encouraging reporting 
can contribute to improve awareness among health personnel and patients about the 
beneﬁ t-harm proﬁ le of the herbal products. 
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OBJECTIVES: In the 1980s, China launched market-oriented reforms. Public hospi-
tals were encouraged to make their own incomes with the aim of mobilizing medical 
workers and improving hospital efﬁ ciency. Less government funding resulted in deﬁ -
cits for public health institutions, which forced hospitals to generate their own revenue 
by aggressively selling drugs, especially antibiotics. This study was designed to evaluate 
the impact of inappropriate antibiotic use on inpatients’ cost during the hospitaliza-
tion. METHODS: One thousand cases with antibiotic treatment from 10 hospitals of 
ﬁ ve provinces in China in 2006. We created multivariate linear regression model for 
hospital cost and logistic regression model for rationality evaluation of antibiotic use. 
RESULTS: Finally we collected 964 valid cases. Rate of inappropriate antibiotic use 
was 58.4%. Costs of inpatients with inappropriate antibiotic use was as 2.75 times 
as the ones with appropriate use (P < 0.001). Risk factors included antibiotic prophy-
laxis (OR = 2.929), operations (OR = 2.44), long hospital stay (OR = 1.021 for every 
prolonged day) and regional factors. Protection factor was in tertiary hospital (OR = 
0.510). CONCLUSIONS: This study concluded that inappropriate antibiotic use 
contributes to inpatients’ high cost. Efforts to control misuse of antibiotic should be 
pursued. 
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OBJECTIVES: Antithrombotic agents have been recommended to prevent venous 
thromboembolism (VTE) after major orthopedic surgeries, yet neither effectiveness 
evidence nor guidance for prophylactic antithrombotic agents is available in Taiwan. 
This study aims to evaluate current utilization of prophylactic antithrombotic agents 
after total hip and knee replacement (THR/TKR). METHODS: This retrospective 
cohort study used a Taiwanese National Health Insurance dataset including 1,000,000 
beneﬁ ciaries randomly sampled in 2005 from nationwide population and followed 
longitudinally from 1995 to 2008. Adults hospitalized for THR or TKR were identi-
ﬁ ed by procedure codes from April 2003 to June 2008. Patients with VTE, bleeding 
events, or antithrombotic prescriptions within 90 days preadmission were excluded. 
Eligible patients’ characteristics, medication during operation, and antithrombotic 
prescription up to 30 days post-admission were collected, presented in descriptive 
statistics, and stratiﬁ ed by different operations. RESULTS: Of all, 1026 THR (41.03% 
women) and 2401 TKR (75.51% women) were identiﬁ ed, with mean age of 56.36 ± 
